financetom
Business
financetom
/
Business
/
DeepSeek gives China's chipmakers leg up in race for cheaper AI
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DeepSeek gives China's chipmakers leg up in race for cheaper AI
Feb 12, 2025 8:08 PM

BEIJING (Reuters) - The rise of DeepSeek's artificial intelligence (AI) models is seen providing some Chinese chipmakers such as Huawei a better chance to compete in the domestic market against more powerful U.S. processors.

Huawei and its Chinese peers have for years struggled to match Nvidia ( NVDA ) in building top-end chips that could compete with the U.S. firm's products for training models, a process where data is fed to algorithms to help them learn to make accurate decisions.

However, DeepSeek's models, which focus on "inference," or when an AI model produces conclusions, optimise computational efficiency rather than relying solely on raw processing power.

That is one reason why the model is expected to partly close the gap between what Chinese-made AI processors and their more powerful U.S. counterparts can do, analysts say.

Huawei, and other Chinese AI chipmakers such as Hygon, Tencent-backed EnFlame, Tsingmicro and Moore Threads have in recent weeks issued statements claiming products will support DeepSeek models, although few details have been released.

Huawei declined to comment. Moore Threads, Hygon EnFlame and Tsingmicro did not respond to Reuters queries seeking further comment.

Industry executives are now predicting that DeepSeek's open-source nature and its low fees could boost adoption of AI and the development of real-life applications for the technology, helping Chinese firms overcome U.S. export curbs on their most powerful chips.

Even before DeepSeek made headlines this year, products such as Huawei's Ascend 910B were seen by customers such as ByteDance as better suited for less computationally intensive "inference" tasks, the stage after training that involves trained AI models making predictions or performing tasks, such as through chatbots.

In China, dozens of companies from automakers to telecoms providers have announced plans to integrate DeepSeek's models with their products and operations.

"This development is very much aligned with the capability of Chinese AI chipset vendors," said Lian Jye Su, a chief analyst at tech research firm Omdia.

"Chinese AI chipsets struggle to compete with Nvidia's ( NVDA ) GPU (graphics processing unit) in AI training, but AI inference workloads are much more forgiving and require a lot more local and industry-specific understanding," he said.

NVIDIA STILL DOMINATES

However, Bernstein analyst Lin Qingyuan said while Chinese AI chips were cost-competitive for inferencing, this was limited to the Chinese market as Nvidia ( NVDA ) chips were still better even for inference tasks.

While U.S. export restrictions ban Nvidia's ( NVDA ) most advanced AI training chips from entering China, the company is still allowed to sell less powerful training chips that Chinese customers can use for inference tasks.

Nvidia ( NVDA ) published a blog post on Thursday about how inference time was rising as a new scaling law and argued that its chips will be necessary to make DeepSeek and other "reasoning" models more useful.

In addition to computing power, Nvidia's ( NVDA ) CUDA, a parallel computing platform that allows software developers to use Nvidia GPUs for general-purpose computing, not just AI or graphics, has become a crucial component of its dominance.

Previously, many Chinese AI chip companies did not directly challenge Nvidia ( NVDA ) by asking users to abandon CUDA but instead, claimed their chips were compatible with CUDA.

Huawei has been the most aggressive in its efforts to break away from Nvidia ( NVDA ) by offering a CUDA equivalent called Compute Architecture for Neural Networks (CANN), but experts said it faced obstacles in persuading developers to abandon CUDA.

"Software performance of Chinese AI chip firms is also lacking at this stage. CUDA has a rich library and a diverse range of software capability, which requires significant long-term investment," said Omdia's Su.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved